ENGLISH WILSON: Open Payments
NPI 1497415301 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 36 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $291 · 2025 $695
Food & beverage: $682Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 3 | $73 |
| Novo Nordisk Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| ABBVIE INC. | 2 | $51 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: REXULTI, NURTEC ODT, TRELEGY ELLIPTA, VRAYLAR, Rybelsus, BREZTRI, The Cologuard Plus Collection Kit, XIFAXAN.
Industry payments across AL — which companies pay providers there.
